United States · Series C startup

Who invested in TransMolecular

One round we have observed, with the 12 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$33Mraised across 1 round since 2004, from 1 source

Latest round
Series C, $33MMar 2004
Investors
12
See who backed them

The rounds

  1. Mar 2004

The exit

ExitBuyerPriceWhen
AcquiredMorphotekundisclosedMar 2001

From historical deal records. Wrong? Tell us.

Everyone who backed them

TVM CapitalPrivate equity1round
Easton CapitalVC firm1round
MDS CapitalGrowth equity1round
POSCO BioVenturesVC firm1round
Pacific Horizon VenturesGrowth equity1round
Tullis-DickersonInvestment firm1round
Cogene VenturesVC firm1round
Dow Pension FundsVC firm1round
Diamond Capital ManagementPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about TransMolecular

Who invested in TransMolecular?

TransMolecular's investors include TVM Capital, Easton Capital, Aperture Venture Partners, Oakwood Medical Investors and MDS Capital, and 7 more on record.

How much has TransMolecular raised?

TransMolecular has raised $33M across 1 round since 2004.

When did TransMolecular last raise?

TransMolecular's most recent round was a Series C of $33M in Mar 2004.

What was TransMolecular's biggest round?

Its most recent round, $33M in Mar 2004, is also its largest on record.

Who backed TransMolecular first?

TransMolecular's first round on record, in Mar 2004, was backed by TVM Capital, Easton Capital and Aperture Venture Partners and 9 others.

What stage is TransMolecular at?

TransMolecular's latest named round is a Series C, in Mar 2004.

Where is TransMolecular based?

TransMolecular is based in the United States.

Companies like TransMolecular

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.